0000000000125499

AUTHOR

Michael Roggendorf

showing 6 related works from this author

An outbreak of HBV and HCV infection in a paediatric oncology ward: Epidemiological investigations and prevention of further spread

2003

Hospital-acquired hepatitis B (HBV) and C virus (HCV) infections continue to occur despite increased awareness of this problem among the medical community. One hundred six patients were infected in a haematology oncology ward for children, over the time period 1996 to 2000. Serum samples from 45 such patients and 3 from infected medical personnel were used for nucleic acid amplification. HBV core, as well as HCV core and hypervariable region 1 (HVR1) nucleotide sequences, were analysed by phylogenetic tree analysis, in order to characterise the epidemiological pattern of viral transmission on the ward. Samples from 32 patients were positive for HBV-DNA or HCV-RNA by PCR. Ten patients were p…

Hepatitis B virusmedicine.medical_specialtyAdolescentMolecular Sequence DataHepacivirusmedicine.disease_causePediatricsPolymerase Chain ReactionDisease OutbreaksFlaviviridaeOncology Service HospitalVirologyEpidemiologymedicineHumansInfection controlChildPhylogenyHepatitis B virusCross InfectionbiologyTransmission (medicine)business.industryIncidence (epidemiology)virus diseasesSequence Analysis DNAHepatitis BHepatitis Bmedicine.diseasebiology.organism_classificationHepatitis CVirologydigestive system diseasesInfectious DiseasesChild PreschoolDNA ViralRNA ViralViral diseasebusinessJournal of Medical Virology
researchProduct

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV)

2005

The major aim of the project was the development of virus-like particles (VLP) displaying B- and T-cell epitopes of hepatitis C virus (HCV) proteins. To this end, hepatitis B virus core (HBc) particles were used as a carrier of HCV epitopes. Fragments of HCV genes encoding core (aa 98) and NS3 (aa 155) proteins were fused to the 3' terminus of the truncated HBV core gene. All recombinant plasmids led to relatively high levels of expression of chimeric proteins in E. coli, which resulted in the formation of complete "mature" VLP. Chimeric HBc/HCV VLPs were purified by combination of gel filtration and sucrose gradient centrifugation, and used for immunogenicity studies in mice. All variants …

ImmunogenT-LymphocytesvirusesHepacivirusBiologyRecombinant virusEpitopeVirusEpitopesMiceVirus-like particleAnimalsCell ProliferationB-LymphocytesMice Inbred BALB CNS3General VeterinaryGeneral Immunology and MicrobiologyImmunogenicityVirionPublic Health Environmental and Occupational Healthvirus diseasesVirologyMolecular biologydigestive system diseasesHBcAgInfectious DiseasesMolecular MedicineElectrophoresis Polyacrylamide GelFemaleVaccine
researchProduct

Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA

1996

Abstract Backgrounds/Aims :In the past few years the detection of HCV-RNA by polymerase chain reaction has become a well-established diagnostic tool for patients with chronic hepatitis C. However, the lack of reproducible results between laboratories and the relatively high proportion of false-positive results, has indicated the need for a standardized and reliable polymerase chain reaction assay. In the present study we have analyzed the performance of a commercial, HCV-RNA polymerase chain reaction assay based on a single, combined reverse transcription and amplification reaction and on the use of Uracil-N-glycosilase to prevent carry-over contamination (Amplicor HCV, Roche Molecular Syst…

HepatitisHepatologybiologyHepacivirusHepatitis C virusHepacivirusHepatitis CHepatitis C Antibodiesmedicine.diseasebiology.organism_classificationmedicine.disease_causeHepatitis CPolymerase Chain ReactionVirologyReverse transcriptaselaw.inventionlawmedicineHumansRNA ViralPrimer (molecular biology)Nested polymerase chain reactionPolymerase chain reactionJournal of Hepatology
researchProduct

Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity

2006

Abstract Plasmids pQE-60 and pQE-30 containing 6× His-tag sequence were used for expression of fragments of HCV structural and non-structural proteins in Escherichia coli (E. coli). The following fragments were used: core (1–98 aa), NS3 (202–482 aa), and tetramer of hypervariable region 1 (HVR1) of E2 protein. The constructed plasmids directed high levels of expression of HCV proteins in E. coli JM109. After purification by the metal-affinity chromatography on nickel–nitrilotriacetic acid (Ni–NTA) agarose, the His-tagged HCV proteins were used for immunization of BALB/c mice. All three proteins were able to induce high levels of specific antibodies and, in the case of the NS3 and HVR1 tetra…

Nitrilotriacetic AcidHepatitis C virusDose-Response Relationship ImmunologicViral Nonstructural ProteinsBiologymedicine.disease_causeSensitivity and SpecificityChromatography AffinityAntigen-Antibody ReactionsMiceViral Proteinschemistry.chemical_compoundPlasmidTetramerNickelmedicineAnimalsCloning MolecularEscherichia coliCell ProliferationMice Inbred BALB CNS3Viral Core ProteinsImmunogenicityvirus diseasesHepatitis C AntibodiesVirologyMolecular biologyPeptide FragmentsRecombinant Proteinsdigestive system diseasesHypervariable regionchemistryAgaroseFemaleImmunizationHepatitis C AntigensPeptidesSpleenBiotechnologyProtein Expression and Purification
researchProduct

Survival After Transplantation of Corneas From a Rabies-Infected Donor

2011

To examine the tissue samples of 2 corneal recipients from a rabies-infected donor for the presence of rabies to explain their survival.Interventional case series with a review of the literature. The explanted corneal donor buttons were examined via nested reverse transcriptase polymerase chain reaction. The patients were followed up ophthalmologically and neurologically. Antirabies antibodies were measured in blood samples, and skin biopsies were examined by direct fluorescent antibody staining.Two patients received corneas from the same multiorgan donor. Six weeks after transplantation, 3 of the donor's organ recipients became symptomatic and rabies virus was confirmed in tissue from the …

AdultCentral Nervous SystemMaleReoperationgenetic structuresRabiesmedicine.medical_treatmentMedizinmedicine.disease_causeCorneal TransplantationMedicineHumansRabies transmissionSurvival rateCorneal transplantationbusiness.industryRabies virusMiddle Agedmedicine.diseaseVirologyeye diseasesReverse transcriptaseTissue DonorsTransplantationSurvival RateOphthalmologyRabies virusRNA ViralRabiesFemalesense organsbusiness
researchProduct

Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus

2010

BACKGROUND: This article describes multiple transmissions of rabies via transplanted solid organ from a single infected donor. The empirical Milwaukee treatment regimen was used in the recipients. METHODS: Symptomatic patients were treated by deep sedation (ketamine, midazolam, and phenobarbital), ribavirin, interferon, and active and passive vaccination. Viral loads and antibodies were continuously monitored. RESULTS: Recipients of both cornea and liver transplants developed no symptoms. The recipient of the liver transplant had been vaccinated approximately 20 years before transplantation. Two recipients of kidney and lung transplants developed rabies and died within days of symptomatic d…

AdultMaleMicrobiology (medical)medicine.medical_specialtyRabiesmedicine.medical_treatmentMedizinLiver transplantationAntibodies Viralmedicine.disease_causeAntiviral AgentsOrgan transplantationmedicineHumansHypnotics and SedativesMononegaviralesLyssavirusAgedbiologybusiness.industryRabies virusOrgan TransplantationMiddle AgedViral Loadmedicine.diseasebiology.organism_classificationSurgeryTransplantationTreatment OutcomeInfectious DiseasesRabies VaccinesRabies virusFemaleRabiesbusinessViral load
researchProduct